Crispr Therapeutics shares owned by Cambridge Investment Research Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Cambridge Investment Research Advisors
from 13F filings
Historical chart of Cambridge Investment Research Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Cambridge Investment Research Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.1M | 24k | 46.99 |
| 2024-06-30 | $1.5M | 29k | 53.99 |
| 2024-03-31 | $3.8M | 56k | 68.16 |
| 2023-12-31 | $3.0M | 48k | 62.59 |
| 2023-09-30 | $1.0M | 23k | 45.39 |
| 2023-06-30 | $1.4M | 25k | 56.15 |
| 2023-03-31 | $1.2M | 26k | 45.24 |
| 2022-12-31 | $1.1M | 27k | 40.63 |
| 2022-09-30 | $1.7M | 26k | 65.36 |
| 2022-06-30 | $1.7M | 28k | 60.75 |
| 2022-03-31 | $1.4M | 22k | 62.76 |
| 2021-12-31 | $1.3M | 17k | 75.75 |
| 2021-09-30 | $2.5M | 22k | 111.92 |
| 2021-06-30 | $4.4M | 28k | 161.89 |
| 2021-03-31 | $2.4M | 20k | 121.85 |
| 2020-12-31 | $2.7M | 18k | 153.10 |
| 2020-09-30 | $925k | 11k | 83.66 |
| 2020-06-30 | $470k | 6.4k | 73.43 |
| 2020-03-31 | $250k | 5.9k | 42.35 |
| 2019-12-31 | $420k | 6.9k | 60.89 |
| 2019-09-30 | $1.5M | 31k | 47.10 |
| 2019-06-30 | $1.5M | 31k | 47.10 |
| 2018-09-30 | $340k | 7.7k | 44.33 |
More positions owned by Cambridge Investment Research Advisors
View all positions for Cambridge Investment Research Advisors